News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi-Aventis (France) (SASY.PA), Vical Incorporated (VICL) Limb Ischemia Drug NV1FGF Fails in Late-Stage Test


9/22/2010 6:58:32 AM

Sept. 22 (Bloomberg) -- Sanofi-Aventis SA said a drug that had showed promise in restoring blood vessel growth in damaged limbs was no better than a placebo in an advanced test.

Read at Reuters
Read at The Street.com
Read at Business Week
Read at Fox News
Read at RTT News


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES